Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Taysha Gene Therapies Inc (NQ: TSHA ) 2.070 -0.080 (-3.72%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Taysha Gene Therapies Inc < Previous 1 2 3 4 5 6 7 Next > 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 01, 2023 Via Benzinga Why TransCode Therapeutics Shares Are Trading Higher By 42%; Here Are 20 Stocks Moving Premarket February 01, 2023 Gainers Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday February 01, 2023 It's time for another look at the biggest pre-market stock movers worth checking out as we start off trading early on Wednesday! Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session January 31, 2023 Via Benzinga Analyst Ratings for Taysha Gene Therapies January 27, 2023 Via Benzinga Expert Ratings for Taysha Gene Therapies January 04, 2023 Via Benzinga Expert Ratings for Taysha Gene Therapies October 26, 2022 Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings within the last quarter: Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session January 30, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023 January 27, 2023 Via Benzinga JMP Securities Maintains Market Outperform Rating for Taysha Gene Therapies: Here's What You Need To Know January 19, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session December 29, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022 November 09, 2022 Upgrades Via Benzinga Earnings Scheduled For November 8, 2022 November 08, 2022 Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 November 08, 2022 Upgrades Via Benzinga Earnings Preview: Taysha Gene Therapies November 07, 2022 Taysha Gene Therapies (NASDAQ:TSHA) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Taysha... Via Benzinga $3 Million Bet On Taysha Gene Therapies? Check Out These 3 Penny Stocks Insiders Are Buying November 03, 2022 The Dow Jones closed lower by more than 500 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... Via Benzinga Why Etsy Shares Are Trading Sharply Higher; Here Are 31 Stocks Moving Premarket November 03, 2022 Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 34.7% to $0.0858 in pre-market trading after gaining over 12% on Wednesday. Via Benzinga Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday October 28, 2022 Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session October 27, 2022 Gainers Via Benzinga Why UserTesting Shares Are Trading Higher By Around 93%? Here Are 53 Stocks Moving In Thursday's Mid-Day Session October 27, 2022 Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) gained 111% to $2.03 after the company announced it entered into a license agreement with Transcosmos Digital Technology for its Apromore process... Via Benzinga US Stocks Mostly Higher; Dow Jumps Over 400 Points October 27, 2022 U.S. stocks traded mostly higher this morning, with the Dow Jones climbing more than 400 points on Thursday. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session October 27, 2022 Gainers Clearside Biomedical (NASDAQ:CLSD) stock rose 27.3% to $1.35 during Thursday's pre-market session. The market value of their outstanding shares is at $81.2 million. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session October 26, 2022 Gainers Via Benzinga Short Volatility Alert: Taysha Gene Therapies, Inc. October 26, 2022 On Tuesday, shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) experienced volatile short activity. After the activity, the stock price went up +97.35% to $2.98. The overall sentiment for TSHA has... Via Benzinga Nasdaq Dips 1.5%; Alphabet Misses Q3 Estimates October 26, 2022 U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 1.5% on Wednesday. Via Benzinga Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday October 27, 2022 Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 26, 2022 Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 47.9% to $0.31 during Wednesday's pre-market session. The company's market cap stands at $11.8 million. Via Benzinga Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session October 26, 2022 Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday October 26, 2022 It's time to start off the day with a breakdown of the biggest pre-market stock movers for Wednesday morning and the latest news! Via InvestorPlace Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday October 26, 2022 Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.